1Autophagy regulation combined with stem cell therapy for treatment of spinal cord injuryYao Shen, Yi-Piao Wang, Xin Cheng, Xuesong Yang, Guang Wang1629-16362FcRn inhibitors: a novel option for the treatment of myasthenia gravisLi-Na Zhu, Hai-Man Hou, Sai Wang, Shuang Zhang, Ge-Ge Wang, Zi-Yan Guo, Jun Wu1637-16443Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer's disease: progress, advantages, and challengesRenata Guedes de Jesus Gon?alves, Juliana Ferreira Vasques, Almir Jord?o da Silva-Junior, Fernanda Gubert, Rosalia Mendez-Otero1645-16514The transient receptor potential melastatin 2: a new therapeutical target for Parkinson's disease?Ana Flávia F.Ferreira, Luiz Roberto G.Britto1652-16565Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injuryYu-Yan Liu, Yun Li, Lu Wang, Yan Zhao, Rui Yuan, Meng-Meng Yang, Ying Chen, Hao Zhang, Fei-Hu Zhou, Zhi-Rong Qian, Hong-Jun Kang1657-16656The role of monocytes in optic nerve injuryXiangxiang Liu, Yuan Liu, Mohamed M.Khodeiry, Richard K.Lee1666-16717Immortalized hippocampal astrocytes from 3xTg-AD mice, a new model to study disease-related astrocytic dysfunction: a comparative reviewLaura Tapella, Giulia Dematteis, Armando A Genazzani, Massimiliano De Paola, Dmitry Lim1672-16788Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trialsBruno P.Imbimbo, Viviana Triaca, Camillo Imbimbo, Robert Nisticò1679-16839The role of purinergic receptors in neural repair and regeneration after spinal cord injuryRui-Dong Cheng, Wen Ren, Ben-Yan Luo, Xiang-Ming Ye1684-169010Role of vascular endothelial growth factor as a critical neurotrophic factor for the survival and physiology of motoneuronsPaula M.Calvo, Rosendo G.Hernández, Rosa R.de la Cruz, Angel M.Pastor1691-169711Prenatal and postnatal drug exposure: focus on persistent central effectsGiulia Costa, Alexia E.Pollack1697-170212Overcoming axon regeneration failure and psychopathology: how may gabapentinoids help boost CNS repair?Haven I.Rodocker, Andrea Tedeschi1703-170413Neuroplastin in Ca2+ signal regulationand plasticity of glutamatergic synapsesAyse Malci, Xiao Lin, Yun Stone Shi, Rodrigo Herrera-Molina1705-170614Gut microbiota neurotransmitters: influence on risk and outcome of ischemic strokeRyszard Pluta, S?awomir Januszewski1707-170815In vitro microglia models: the era of engineered cell microenvironmentsAhmed Sharaf, Raissa Timmerman, Jeffrey Bajramovic, Angelo Accardo1709-171016Augmentation of transforminggrowth factor-β signaling for the treatment of neurological disordersJian Luo1711-171217Therapeutic potential of lysosomal cathepsins for neurodegenerative diseasesSusy Prieto Huarcaya, Friederike Zunke1713-171418Neurovascular unit permeability in neuroinflammatory diseases: a common pathologic and therapeutic target?Molly Monsour, Cesar V.Borlongan1715-171619Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammationDumitru Ciolac, Gabriel Gonzalez-Escamilla, Yaroslav Winter, Vinzenz Fleischer, Matthias Grothe, Sergiu Groppa1717-171820Oxidative stress in N88S seipinopathy: novel insights into the mechanisms of neurodegeneration and therapeutic avenuesVítor Costa, Vitor Teixeira1719-1720 